Jublia (efinaconazole 10% topical solution) kills toenail fungus by blocking a key enzyme that fungi need to build their cell membranes. You apply it once daily to affected toenails for 48 weeks, and its specially designed formula allows it to penetrate through the hard nail plate to reach the infection underneath.
How Jublia Attacks Fungal Cells
Fungi rely on a substance called ergosterol to keep their cell membranes intact and functional, much like cholesterol in human cells. Jublia’s active ingredient, efinaconazole, blocks the enzyme responsible for a critical step in ergosterol production. Without this enzyme working properly, the fungal cell can’t produce ergosterol. Instead, abnormal sterols accumulate inside the cell, weakening the membrane and ultimately stopping the fungus from growing and surviving.
This mechanism is shared across a class of antifungals called azoles, but efinaconazole was specifically developed for topical use on nails rather than oral use throughout the body. That means it concentrates its effects at the site of infection rather than circulating through your bloodstream.
How It Gets Through the Nail
The biggest challenge with treating toenail fungus topically is the nail itself. The hard, keratinized nail plate acts as a physical barrier that most liquids can’t easily cross. Jublia’s formulation was engineered with a low surface tension, which helps it spread across and soak into the nail more effectively than a standard liquid would. Think of it like the difference between water beading up on a waxed surface versus spreading flat across glass.
Once through the nail plate, the solution also spreads into the space between the nail and the nail bed, which is where the fungus typically lives. This two-step delivery (through the nail and then underneath it) is central to how the drug reaches the infection. You apply it with a built-in brush applicator that helps distribute the solution evenly across the affected nail.
What the Clinical Trials Showed
Jublia was tested in two large phase 3 trials involving over 1,600 patients. At the end of 52 weeks (48 weeks of treatment plus a 4-week follow-up), the results were modest but significantly better than placebo:
- Complete cure (no visible fungus plus negative lab tests): 17.8% in Trial 1 and 15.2% in Trial 2, compared to 3.3% and 5.5% with the inactive vehicle alone.
- Mycological cure (lab tests confirming the fungus was eliminated, even if the nail still looked abnormal): 55.2% in Trial 1 and 53.4% in Trial 2, compared to about 17% with placebo.
The gap between mycological cure and complete cure is important to understand. More than half of patients successfully killed the fungus, but the nail hadn’t fully grown out clear by week 52. Toenails grow slowly, often taking 12 to 18 months to fully replace themselves. So even after the fungus is gone, it can take additional months for the nail to look normal again.
How to Use It
The treatment protocol is straightforward but requires patience. You apply Jublia to the affected toenail once a day, every day, for 48 weeks. That’s nearly a full year of daily application. The integrated brush applicator makes it easy to coat the nail surface, and you should also let it flow along the edges of the nail where it meets the skin, since the solution is designed to wick underneath.
Consistency matters. Missing applications gives the fungus time to regrow between doses, potentially undermining months of progress. Most people apply it at the same time each day, often before bed, to build it into a routine.
Side Effects
Because Jublia is applied topically and has minimal absorption into the bloodstream, systemic side effects are rare. The most common issues are local reactions at the application site: skin irritation (dermatitis), small blisters (vesicles), and occasional pain. Ingrown toenails have also been reported. These reactions occurred in a small percentage of patients in clinical trials and were generally mild enough that most people continued treatment.
How It Compares to Other Topical Options
The other major topical treatment for toenail fungus is ciclopirox lacquer, which works through a completely different mechanism. Rather than targeting a single enzyme, ciclopirox disrupts multiple processes in fungal cells. Lab studies comparing the two found that ciclopirox actually penetrated nail tissue at higher concentrations, with roughly 10 times greater permeability through nail-like membranes than Jublia’s formulation.
However, clinical cure rates tell a more complex story, and Jublia’s phase 3 results were strong enough to earn FDA approval in 2014. One consideration is that lab testing found the fungus most commonly responsible for toenail infections was more likely to develop resistance to efinaconazole than to ciclopirox. This is a theoretical concern for long-term or repeated treatment courses, though it hasn’t been widely studied in real-world patients.
Topical treatments in general are best suited for mild to moderate cases, particularly when the fungus affects less than half the nail and hasn’t reached the base (the lunula). For more severe or widespread infections, oral antifungal medications typically achieve higher cure rates because they deliver the drug through the bloodstream directly into the growing nail.
Setting Realistic Expectations
A complete cure rate of 15 to 18% may sound low, but context matters. Toenail fungus is notoriously difficult to treat by any method, and a mycological cure rate above 50% means the drug is eliminating the infection in the majority of patients. The nail just needs time to grow out and look normal. If your nail hasn’t improved after a full 48-week course, your provider may recommend a different approach, including oral medication or combination therapy.
Even after successful treatment, toenail fungus has a high recurrence rate. The same warm, damp environment inside shoes that caused the original infection can reintroduce it. Keeping feet dry, wearing moisture-wicking socks, and treating athlete’s foot promptly can help prevent reinfection after you’ve completed a Jublia course.